Tobira amends IPO

Tobira Therapeutics Inc. (San Francisco, Calif.) amended the terms for its proposed IPO on NASDAQ underwritten by Oppenheimer & Co., removing the price range, the number of shares and several of the underwriters. The company on Aug. 7 said it would postpone the offering, but did not give a reason (see BioCentury Extra, Aug. 7).

Tobira, which had filed under provisions of the Jumpstart Our Business Startups (JOBS) Act, had previously listed BMO Capital Markets; JMP Securities; and Nomura as additional underwriters in July, but did not name them in its amended filing. Oppenheimer was among the original underwriters. The company's financial spokesperson was not available for comment regarding the changes. ...